Bill116th CongressFiled Feb 5, 2019Health
H.R. 985
FAST Generics Act of 2019
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (Feb 5, 2019)
Fair Access for Safe and Timely Generics Act of 2019 or the FAST Generics Act of 2019
This bill generally prohibits the license holder of a drug or biological product approved by the Food and Drug Administration from restricting availability of the drug or product for testing by a product developer seeking to develop a drug, generic drug, or biosimilar.
What just happenedFeb 5, 2019
Referred to the House Committee on Energy and Commerce.
Who’s behind it
Rep. Welch, Peter [D-VT-At Large](D-VT)Sponsor
4 cosponsors3 D1 R
4cosponsors1committees3actions4subjects
- Introduced in HouseFeb 5, 2019
- Feb 5, 2019IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Feb 5, 2019IntroReferralIntro-H
Introduced in House
- Feb 5, 2019IntroReferral1000
Introduced in House